$SLXP Roth Capital Moves To The Sideline On Salix Pharmaceuticals; Cuts PT To $95 http://www.smarteranalyst.com/2014/11/07/roth-capital-moves-to-the-sideline-on-salix-pharmaceuticals-cuts-pt-to-95/ This is another one - less positive.